Physician profile
Se Kon Won
NPI 1881633865
$11,214.84
in general payments reported to CMS, 2019-2025
23 companies · $1,832 in 2025
The $1,832 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,881 · 2020: $653 · 2021: $130 · 2022: $2,639 · 2023: $1,185 · 2024: $895 · 2025: $1,832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,438 · Travel and Lodging: $388 · Education: $85.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,438.46 |
| Travel and Lodging | $387.74 |
| Education | $85.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,752.27 | 2019-2025 | Agilis Hispro, Aveir, Xience Skypoint |
| Boston Scientific Corporation | $842.21 | 2019-2025 | Watchman |
| Abiomed | $740.01 | 2021-2024 | Impella |
| Novo Nordisk INC | $460.59 | 2023-2025 | Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $335.74 | 2024-2025 | Jardiance |
| Teleflex LLC | $294.34 | 2022-2025 | Guideliner, Supercross |
| Bridgebio Pharma, INC. | $263.70 | 2025 | Attruby |
| Shockwave Medical, INC | $245.14 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lantheus Medical Imaging, INC. | $222.07 | 2019-2025 | Definity |
| Astrazeneca Pharmaceuticals LP | $171.05 | 2023-2024 | Wainua, Farxiga |
| Alnylam Pharmaceuticals INC. | $167.87 | 2025 | Amvuttra |
| Acist Medical Systems, INC. | $150.30 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $125.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.56 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $82.39 | 2022-2025 | Camzyos, Eliquis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $58.76 | 2021-2025 | Micra, Selectsecure |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.50 | 2024 | Lifevest |
| Cardiovascular Systems INC. | $31.03 | 2019 | |
| Esperion Therapeutics, INC. | $25.13 | 2022 | |
| Amgen INC. | $21.58 | 2025 | Repatha |
| Biosense Webster, INC. | $19.07 | 2022 | |
| Penumbra, INC. | $17.40 | 2022 | |
| Chiesi USA, INC. | $13.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Se Kon Won listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.